Chin-chang W. Huang
No. 199, Tun Hwa North Road, 10547Taiwan
Tunisia
Tunisia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
ADAS-Cog11 performance as a surrogate of tau PET burden in an Asian Alzheimer's disease cohort.
Journal: Journal of Alzheimer's disease : JAD
Published: April 17, 2026
Long-Term Liver Outcomes in Wilson's Disease: Predictors of Survival and Hepatocellular Carcinoma.
Journal: Clinical and molecular hepatology
Published: April 01, 2026
A clinically feasible framework to estimate tau pathology and clinical-biological discordance in the Alzheimer's disease spectrum.
Journal: Alzheimer's research & therapy
Published: February 27, 2026
Taiwan Clinical Practice Guidelines for Myasthenia Gravis.
Journal: Acta neurologica Taiwanica
Published: June 06, 2025
Visual interpretation of [18F]Florzolotau Tau-PET imaging for differentiating alzheimer's disease and progressive supranuclear palsy.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 12, 2025
The Taiwan-ADNI workflow toward integrating plasma p-tau217 into prediction models for the risk of Alzheimer's disease and tau burden.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: May 01, 2024
Human biodistribution and radiation dosimetry for the tau tracer [18F]Florzolotau in healthy subjects.
Journal: EJNMMI radiopharmacy and chemistry
Published: January 25, 2024
Epidemiology and diagnostic challenges in neuromyelitis optica spectrum disorder in Taiwan: a hospital-based surveillance accompanied by a nationwide study.
Journal: Brain communications
Published: January 09, 2024
Impact of comorbidities on relapsing rates of Neuromyelitis Optica Spectrum Disorders: Insights from a longitudinal study in Taiwan.
Journal: Multiple sclerosis and related disorders
Published: July 24, 2023
Visual reading for [18F]Florzolotau ([18F]APN-1607) tau PET imaging in clinical assessment of Alzheimer's disease.
Journal: Frontiers in neuroscience
Published: January 26, 2023
Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a study.
Journal: EBioMedicine
Published: January 05, 2023
Last Updated: 09/26/2026